Spastic paraplegia of unknown origin. A follow-up of 32 patients.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001161:Arteriosclerosis / Q000150:complications; D002556:Cerebrospinal Fluid Proteins; D004679:Encephalomyelitis / Q000150:complications; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006984:Hypertrophy / Q000150:complications; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders; D009103:Multiple Sclerosis / Q000150:complications; D009128:Muscle Spasticity / Q000175:diagnosis / Q000209:etiology* / Q000235:genetics; D009192:Myelography; D010264:Paraplegia / Q000175:diagnosis / Q000209:etiology* / Q000235:genetics; D013118:Spinal Cord Diseases / Q000150:complications; D013168:Spondylolisthesis / Q000150:complications; D013595:Syringomyelia / Q000150:complications; D014555:Urination Disorders
D002556:Cerebrospinal Fluid Proteins